Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada

  1. Raphael Ximenes
  2. Alison E. Simmons
  3. Gebremedhin B. Gebretekle
  4. Austin Nam
  5. Eva Wong
  6. Marina I. Salvadori
  7. Alyssa R. Golden
  8. Beate Sander
  9. Kyla J. Hildebrand
  10. Matthew Tunis
  11. Ashleigh R. Tuite
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.vaccine.2025.126985
  2. Version published to 10.1101/2024.10.21.24315770v1 on medRxiv